A Beginners Guide to Immunotherapy - Half-day Course

In the half-day course, Elaine will explain the relationship between cancer cells and the patient’s immune system. She will then go on to describe the logic behind many immunotherapy-based cancer treatments. Treatments explained will include checkpoint inhibitors (ipilimumab, pembrolizumab, nivolumab, atezolizumab, durvalumab), adoptive cell transfer (CAR T cell therapy, infiltrating T cells), and vaccine-based treatments (peptide and DNA vaccines, oncolytic viruses, dendritic cell vaccines).